Meeting Dr. Carolyn Bertozzi, the 2022 Chemistry Nobel Laureate
I never would have imagined that I would be speaking alongside the distinguished Carolyn Bertozzi ( 2022 Chemistry Nobel Laureate ) at the 25th CBA ( Chinese Bioscience Association ) annual conference.
As a great fan of Dr. Bertozzi’s work, I had the opportunity to meet her in person and learn about her inspiring journey in discovering bioorthogonal chemistry.
Bioorthogonal chemistry – the study of chemical reactions to biomolecules, often found on cell surfaces, in living organisms without affecting the chemistry of the cells being observed – was also part of the core intellectual properties behind Good AI’s portfolio Mekonos’ precision gene/cell therapy delivery technologies.
The key to gene and cell therapies are delivery, delivery, delivery!
Carolyn Bertozzi on gene/cell therapies delivery
While there have been great advances in gene and cell therapies, their delivery – doing chemistry inside living patients to make sure drugs go to the right place and not to the wrong place – remains a challenge.
With IPs from Stanford, Mekonos is developing a System-On-a-Chip ( SoC ) platform that will enable molecular delivery in gene editing and synthetic biology. Blending innovations from MEMS (micro-electromechanical system), Microfluidics, and Surface Chemistry, Mekonos' technology is enabling a new level of precision and scalability for cell/gene therapy delivery.
Sharing this mission in tackling the delivery challenges, Mekonos was able to recruit Dr. Carolyn Bertozzi to be its scientific advisor since its founding.
As one of the earliest investors in Mekonos, we are incredibly honored that we got to know Dr. Bertozzi through the investment.